Suppr超能文献

急诊科床边 D-二聚体检测:一项生物等效性研究。

Point of care D-dimer testing in the emergency department: a bioequivalence study.

机构信息

Emergency Department, Westmead Hospital, Sydney, Australia.

出版信息

Ann Lab Med. 2013 Jan;33(1):34-8. doi: 10.3343/alm.2013.33.1.34. Epub 2012 Dec 17.

Abstract

BACKGROUND

D-dimer is used widely as a diagnostic aid in low- and moderate-risk patients with suspected venous thromboembolism (VTE). While our laboratory utilizes VIDAS D-dimer analyzer (bioMérieux SA, France), our emergency department (ED) recently procured a D-dimer analyzer AQT90 FLEX (Radiometer Medical ApS, Denmark) for point of care testing (POCT) to facilitate patient management. We aimed to determine whether the time taken to receive D-dimer results using the 2 different analyzers differed significantly and to quantify the limits of agreement between the results of the 2 methods measured on the same patient.

METHODS

Adult patients presenting to the ED and requiring diagnostic workup for suspected VTE were included in this prospective observational study. Patients underwent simultaneous D-dimer measurements using the 2 different analyzers.

RESULTS

The paired results from 104 patients were analyzed. The median time for the D-dimer results from triage by VIDAS was 258 min (Inter-quartile range [IQR], 173-360) and by POCT was 146 min (IQR, 55-280.5); the median time difference was 101.5 min (IQR, 82-125.5). On an average, POCT D-dimer values were 15% lower on the same sample (limits of agreement, 34-213%). POCT predicted 83% of VIDAS positive results (sensitivity, 83.3% [95% confidence interval (CI), 70.4-91.3%]; specificity, 100% [95% CI, 93.6-100%]). All patients with positive imaging were identified correctly by both methods.

CONCLUSIONS

POCT delivers D-dimer results in significantly shorter turnaround times than pathology services; however, poor bioequivalence between VIDAS and POCT raises the issue of acceptability for use in the ED.

摘要

背景

D-二聚体广泛用作疑似静脉血栓栓塞症(VTE)的低危和中危患者的辅助诊断。虽然我们的实验室使用 VIDAS D-二聚体分析仪(法国生物梅里埃公司),但我们的急诊部门最近购买了一台 D-二聚体分析仪 AQT90 FLEX(丹麦雷度米特医疗公司)用于即时检测(POCT),以方便患者管理。我们旨在确定使用这两种不同分析仪获得 D-二聚体结果所花费的时间是否有显著差异,并量化两种方法在同一患者上测量的结果之间的协议限。

方法

这项前瞻性观察研究纳入了就诊于急诊并需要进行疑似 VTE 诊断检查的成年患者。患者接受了两种不同分析仪的同时 D-二聚体测量。

结果

对 104 名患者的配对结果进行了分析。VIDAS 分诊的 D-二聚体结果中位数为 258 分钟(IQR,173-360),POCT 中位数为 146 分钟(IQR,55-280.5);中位数时间差异为 101.5 分钟(IQR,82-125.5)。平均而言,同一样本上 POCT 的 D-二聚体值低 15%(协议限,34-213%)。POCT 预测了 83%的 VIDAS 阳性结果(灵敏度,83.3%[95%置信区间(CI),70.4-91.3%];特异性,100%[95% CI,93.6-100%])。两种方法均正确识别出所有阳性影像学的患者。

结论

POCT 提供的 D-二聚体结果的周转时间明显短于病理科服务;然而,VIDAS 和 POCT 之间的生物等效性较差,引发了在急诊使用的可接受性问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa1/3535194/14626f76d609/alm-33-34-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验